Drug intelligence / Profile preview

EasyDay

Development stage: Unknown
Lead developer: Omisan Farmaceutici
Administration: Ophthalmic

Overview

EasyDay is an over-the-counter (OTC) ophthalmic solution developed and manufactured by Omisan Farmaceutici. Classified as a medical device, it is formulated as refreshing and lubricating eye drops intended to alleviate ocular discomfort caused by environmental factors such as wind, smoke, sun, or prolonged use of digital screens. The formulation typically features distilled plant waters, including Chamomile (Matricaria chamomilla) for its soothing properties, Hamamelis (Hamamelis virginiana) for its astringent effects, and Euphrasia (Euphrasia officinalis) for its refreshing qualities. It provides a protective and hydrating film on the ocular surface, helping to restore comfort and reduce redness and irritation.

Brand names: EasyDay

Beyond the preview

Go deeper on EasyDay.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EasyDay.

Explore the full profile